124 related articles for article (PubMed ID: 3894261)
21. Immunohistological characterization of a monoclonal antibody (OV632) against epithelial ovarian carcinomas.
Fleuren GJ; Coerkamp EG; Nap M; vd Broek LJ; Warnaar SO
Virchows Arch A Pathol Anat Histopathol; 1987; 410(6):481-6. PubMed ID: 3105167
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibody recognizing a carcinoembryonic antigen epitope differentially expressed in human colonic carcinoma versus normal adult colon tissues.
Zhang HZ; Ordonez NG; Batsakis JG; Chan JC
Cancer Res; 1989 Oct; 49(20):5766-73. PubMed ID: 2477148
[TBL] [Abstract][Full Text] [Related]
23. Circulating tumor-associated antigen detected by the murine monoclonal antibody CF511 in human epithelial ovarian carcinoma.
Murae M; Ohkawa K; Kimura E
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1841-8. PubMed ID: 2687410
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies against antigens expressed on human hepatocellular carcinoma cells.
Hu CP; Han SH; Lui WY; Hsu HC; Lin YM; Lin PH; Chen LR; Hsieh HG; Kuo PT; P'eng FK
Hepatology; 1986; 6(6):1396-402. PubMed ID: 3025071
[TBL] [Abstract][Full Text] [Related]
25. Murine monoclonal antibody LAM2 defines cell membrane determinant with preferential expression on human lung small-cell carcinoma and squamous-cell carcinomas.
Stahel RA; Speak JA; Bernal SD
Int J Cancer; 1985 Jan; 35(1):11-7. PubMed ID: 2578439
[TBL] [Abstract][Full Text] [Related]
26. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
27. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies that discriminate between human ovarian carcinomas and benign ovarian tumours.
Boerman OC; Makkink WK; Thomas CM; Hanselaar AG; Yedema CA; Kenemans P; Poels LG
Eur J Cancer; 1990 Feb; 26(2):117-27. PubMed ID: 2138906
[TBL] [Abstract][Full Text] [Related]
29. Production of a monoclonal antibody specific for seminomas and dysgerminomas.
Bailey D; Baumal R; Law J; Sheldon K; Kannampuzha P; Stratis M; Kahn H; Marks A
Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5291-5. PubMed ID: 3523489
[TBL] [Abstract][Full Text] [Related]
30. Identification of a human cancer-associated antigen defined with monoclonal antibody.
Bhattacharya M; Chatterjee SK; Barlow JJ
Cancer Res; 1984 Oct; 44(10):4528-34. PubMed ID: 6380708
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of epithelial ovarian neoplasm immunologic reactivity using monoclonal antibodies].
Bar J; Sobańska E
Ginekol Pol; 1994 Sep; 65(9):502-7. PubMed ID: 7721163
[TBL] [Abstract][Full Text] [Related]
32. Development of a cell surface reacting human monoclonal antibody recognizing ovarian and certain other malignancies.
Freedman RS; Ioannides CG; Tomasovic B; Patenia R; Zhang HZ; Liang JC; Edwards CL
Hybridoma; 1991 Feb; 10(1):21-33. PubMed ID: 2032733
[TBL] [Abstract][Full Text] [Related]
33. Detection of epithelial ovarian-cancer-associated antigens involved in immune complexes by monoclonal antibodies.
Kawata M; Sekiya S
Tumour Biol; 1998; 19(1):1-11. PubMed ID: 9422077
[TBL] [Abstract][Full Text] [Related]
34. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
[TBL] [Abstract][Full Text] [Related]
35. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
Molinolo A; Simpson JF; Thor A; Schlom J
Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
[TBL] [Abstract][Full Text] [Related]
36. Comparative immunohistochemical study of four monoclonal antibodies directed against ovarian carcinoma-associated antigens.
Boerman OC; van Niekerk CC; Makkink K; Hanselaar TG; Kenemans P; Poels LG
Int J Gynecol Pathol; 1991; 10(1):15-25. PubMed ID: 2007534
[TBL] [Abstract][Full Text] [Related]
37. Six new monoclonal antibodies to serous, mucinous, and poorly differentiated ovarian adenocarcinomas.
Mettler L; Radzun HJ; Salmassi A; Köchling W; Parwaresch MR
Cancer; 1990 Apr; 65(7):1525-32. PubMed ID: 2178766
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibody against ependymoma-derived cell line.
Mihara Y; Matsukado Y; Goto S; Ushio Y; Tokumitsu S; Takahashi K
J Neurooncol; 1992 Jan; 12(1):1-11. PubMed ID: 1541975
[TBL] [Abstract][Full Text] [Related]
39. Establishment of a murine monoclonal antibody against human clear cell carcinoma and analysis of the corresponding antigen.
Nakagawa S; Tsuji Y; Masuda N; Nishiura H; Isojima S
Gynecol Oncol; 1987 Nov; 28(3):318-29. PubMed ID: 2445637
[TBL] [Abstract][Full Text] [Related]
40. Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511.
Ohkawa K; Tsukada Y; Murae M; Kimura E; Takada K; Abe T; Terashima Y; Mitani K
Br J Cancer; 1989 Dec; 60(6):953-60. PubMed ID: 2605105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
